Karin Nicholson, PhD, BCMAS

Principal Scientist Medical & Scientific Affairs
Haleon
Warren, New Jersey

Dr Karin Nicholson is a Principal Scientist in US Medical & Scientific Affairs at Haleon in the Pain Relief category. After earning a PhD in Biochemistry from Princeton University and completing postdoctoral studies in cellular neuroscience at Weil Medical College, she transitioned to the Consumer Healthcare industry. She has worked in the Consumer Healthcare space for over 15 years supporting iconic brands including Listerine, Mucinex and Voltaren in the oral health, respiratory and pain relief categories.

Presentation(s):

• P-080 - (Poster #80) A Global Pain Index Assessment of the Emotional and Psychological Impact of Pain and Its Contribution to Isolation in the Elderly

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-083 - (Poster #83) A prospective, real-world evidence study evaluating the effect of topical diclofenac (Voltaren gel) on functional mobility and quality of life in adults with osteoarthritis of the knee

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-081 - (Poster #81) Clinical Evidence with the Combination of Ibuprofen and Diphenhydramine for the Management of Pain and Sleeplessness

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• P-084 - (Poster #84) Comparative Systemic Bioavailability of Topical Diclofenac Sodium Gel 1% vs Topical Diclofenac Diethylamine Gel 1.16%

  Thursday, September 4, 2025
  4:00 PM - 5:30 PM PST

• SAP-04 - (Scientific Abstract Presentation) A prospective, real-world evidence study evaluating the effect of topical diclofenac (Voltaren gel) on functional mobility and quality of life in adults with osteoarthritis of the knee

  Thursday, September 4, 2025
  4:20 PM - 4:30 PM PST